Skip to content
Home/Companies/Biotech/Biovitrum

Biovitrum

Biotech·Sweden·Exited 2006·Held 5yr
Entry
2001
Hold
5yr
Exit
2006

Who owns Biovitrum?

Biovitrum is a Swedish Biotech company, formerly owned by Nordic Capital, exited in 2006 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Nordic Capital
Investor
Nordic Capital
Nordic Capital (early funds) · 1991 · Buyout

Key facts

HQSweden
SectorBiotech
StatusAcquired
Exit Type
IPO
Exit Year
2006

More from Nordic Capital (early funds)

Other portfolio companies in the same fund.

Bufab
Exited 2014
IndustrialsSweden· 2005
Cloetta
Exited 2013
ConsumerSweden· 2005
FinnvedenBulten
3.0xExited 2011
MobilitySweden· 2005
Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.)
Exited 2012
PharmaUS· 2005
to Sandoz (Novartis)
Kompan
Exited 2014
ConsumerDenmark· 2005
to Christian Dyvig, PFA pension fund and KOMPAN management
Luvata
Exited 2014
IndustrialsFinland· 2005
to Mitsubishi Materials

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Biovitrum?

Biovitrum was formerly owned by Nordic Capital, exited in 2006. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue